Monday, July 27, 2026 · Five AI analysts screened this index for stocks with the best shot at gaining +5% within 30 days
Neutral Normal choppiness · VIX 19.3
The market shows a sharp rotation: AI/semiconductor momentum names are in a severe multi-week correction (Intel, Marvell, Applied Materials, Lam Research, SanDisk all down 20-40%), while financials, insurance, energy, defense, and select retail/healthcare names are rallying steadily and sitting near 52-week highs. This dispersion suggests capital is rotating out of high-multiple tech into value and cyclicals rather than a broad risk-off event, but elevated volatility and this week's Meta/Amazon earnings are near-term wildcards.
Howmet Aerospace makes engine parts and components for jet aircraft. The stock has been rising steadily on strong demand from the aerospace and defense sector rotation, and its upcoming earnings report could act as a further catalyst if results are strong. The main risk is that the same earnings report could disappoint and quickly erase recent gains.
Why the AI likes it
What could go wrong
Calibrated probability: 74% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
General Motors makes and sells cars and trucks including Chevrolet, GMC, and Cadillac. Shares have jumped over the past week on renewed investor optimism, and the stock now trades well above its key moving averages. The main risks are heavy recent insider selling by top executives and the ever-present threat of a slowdown in auto demand.
Why the AI likes it
What could go wrong
Calibrated probability: 78% (raw model estimate: 70%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Quest Diagnostics runs the medical testing labs doctors use for blood work and other diagnostics. The company just reported double-digit revenue and profit growth and explicitly raised its full-year forecast, a sign that demand for its testing services is accelerating. The main risk is that the stock has already climbed and technical indicators are creeping toward overbought territory.
Why the AI likes it
What could go wrong
Calibrated probability: 74% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
JPMorgan is the largest U.S. bank, providing everything from checking accounts to Wall Street trading services. Its stock has been climbing steadily, beating the overall market as investors rotate into financial stocks, and the technical picture, with price above both key moving averages, supports further upside. The main risk is that this bank-stock rally could stall if the broader market pulls back or rate expectations shift.
Why the AI likes it
What could go wrong
Calibrated probability: 74% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
Allstate sells auto and home insurance to millions of U.S. households. The stock has surged as insurers benefit from favorable pricing trends, and it recently beat earnings expectations, both fueling strong momentum. The main risk is a pullback after such a fast run-up, especially with another earnings report due in about a week.
Why the AI likes it
What could go wrong
Calibrated probability: 74% (raw model estimate: 67%) — adjusted using the accuracy of past resolved picks.
Trade math
Suggested allocation is half-Kelly sizing guidance capped at 10% — not personal investment advice. Allocations are scaled to 85% of half-Kelly for the current market regime.
What each AI analyst estimated
This report identifies stocks with an AI-assessed probability of gaining +5% within 30 calendar days (target exit by August 26, 2026). Picks are ranked by how many independent AI agents agreed — more agreement means higher conviction. The guide below tells you exactly how to act on them.
Step-by-Step Action Plan
Position Sizing by Conviction Tier
Size each position according to the coloured border on its pick card. Cap your total exposure across all picks from this report at 25% of your overall trading budget.
| Agents Agreeing | What It Means | Max Allocation Per Pick |
|---|---|---|
| 5/5 | Highest conviction — all five independent analytical checks passed | Up to 10% |
| 4/5 | Very high conviction — four of five independent checks aligned | Up to 8% |
| 3/5 | High conviction — three agents independently agreed | Up to 6% |
| 2/5 | Moderate conviction — two agents independently agreed | Up to 4% |
| 1 Agent | Speculative — solo pick, admitted only at Very High confidence | Up to 2% |
The Three Exit Rules
A plain-English guide to every figure shown on each pick card — what it means, how it is calculated, and what a good or bad value looks like.
Scout scanned 503 S&P 500 constituents and short-listed 26 candidates for deep analysis by the five analysts. Here is what happened to each one.
Checks 30-day price history for every candidate before making any selection. Requires positive period return and positive 5-day momentum as mandatory gates. Ranks picks by proximity to their period high and adjusts probability based on volume. Uses news only to rule out major negative catalysts.
Searches earnings results, analyst upgrades, and revenue trends before checking price data. Requires at least one verifiable fundamental catalyst — earnings beat, analyst upgrade, or revenue acceleration — within the last 60 days. Favours stocks with strong fundamentals trading below recent highs (value entry).
Hunts for specific events within the last 21 days: FDA approvals, major contract wins, product launches, earnings surprises, or significant analyst upgrades. Requires a positive price reaction confirming the market is recognising the catalyst. Also scans for upcoming events that could drive further gains.
Maps the macroeconomic regime (risk-on / risk-off / neutral) and identifies sectors benefiting from current conditions before looking at individual stocks. Only selects stocks from macro-aligned sectors with confirmed sector tailwinds. Adjusts for interest rate sensitivity and geopolitical factors.
Reviews the final picks after all four analysts agree and actively challenges each bull thesis. Searches for bearish technical signals, negative news, insider selling, and elevated short interest that the agreeing agents may have underweighted. Produces evidence-based counter-arguments shown on each pick card.
Pure-quant analyst: no news, no narrative, only numbers. Identifies mean-reversion setups from RSI extremes (<35) with momentum turning, Bollinger squeeze breakouts, and multi-factor quant scores using RSI, MACD, OBV, short interest, and insider transaction data. Counterbalances narrative bias across the four analyst agents.